Studies

  • NCT04832932
  • NCT03451994
  • NCT03582826
  • NCT02692495
  • NCT02683876

    COVID-19

  • MEBO/PATM: 6/21/2021
  • Autoimmunity: 5/16/2021
  • Anaphylaxis: 3/20/2021
  • Genes and Proteins: 4/13/2020
  • Sniffing COVID: 6/20/2020
  • Personalized vaccines: 5/21/2020

    Other Blog Posts

  • COVID-19 in MEBO/PATM COMMUNITY

        June 21, 2021   


    Infections have been shown to alter body odor and so have immunizations. So far, only nonhuman animals were able to detect the subtle changes in chemical makeup after vaccinations and even their sensitive noses were not able to differentiate between different vaccines - such as the rabies virus or the West Nile virus vaccines [Kimball et al, 2014]. However, this was the case of very mild reactions to immunization. Even slightly stronger inflammatory responses, to relatively weak immune challenges, can, indeed, be detected by human noses [Gordon et al, 2018]. Urine and axillary odor are becoming slightly more aversive in healthy humans, as a function of immune activation. But this is not supposed to last too long.

    Our preliminary results, based on responses to the survey for 24 members of MEBO community and 6 of their family members show a wide variety of reactions to Astrazeneca, J&J, Moderna, Pfizer and Sinovac/Coronavac vaccines. 

    Interestingly, Pfizer vaccine that caused no or very mild reactions in several MEBO participants, was also the vaccine that possibly caused temporary worsening of odor symptoms in one person in the community. Another MEBO participant that reported possible worsening of odor from Moderna vaccine had one thing in common with the other individual - they both had pre-existing conditions related to their upper digestive tract. Some Astrazeneca recipients also reported odor issues but did not think it was worse than usual. 

    One of the most interesting observations was that even though only 2 members of MEBO/PATM community reported COVID-19 infection (before or between vaccinations), both of them had long COVID with long-term neurological manifestations such as fatigue, ENT symptoms and loss of smell.

    Adverse reactions to COVID-19 vaccines are influenced by a multitude of factors, many of which can be anticipated and alleviated. A certain level of inflammation is needed to trigger an effective adaptive immune response, but more research is needed to understand who is more likely to experience particular symptoms after infection and from the vaccine.

    You can help by telling us about your experiences with COVID-19 and/or vaccinations. These surveys can be used for posting brief stories - no need to answer all the questions. And you can always add to your story later. Please use your anonymous ID and let us know if you have any questions.

    Survey

    in English:  https://bit.ly/BTN-eng

    en Español: https:/bit.ly/BTN-esp


    We'll be posting more observations and comparisons with over 600 participants of our study from other communities. 


    REFERENCES

    Blumental S, Debré P. Challenges and issues of anti-SARS-CoV-2 vaccines. Frontiers in Medicine. 2021;8.

    Gordon AR, Kimball BA, Sorjonen K, Karshikoff B, Axelsson J, Lekander M, Lundström JN, Olsson MJ. Detection of inflammation via volatile cues in human urine. Chemical senses. 2018 Nov 1;43(9):711-9.

    Kimball BA, Opiekun M, Yamazaki K, Beauchamp GK. Immunization alters body odor. Physiology & behavior. 2014 Apr 10;128:80-5.


    Other related blog posts


    April 7, 2021: Vaccine to cure body odor? There could be a vaccine for everything. But there are still a lot of unknowns when it comes to individual differences in reactions to existing vaccines.


    March 20, 2021: Anaphylaxis to COVID-19 vaccines : What do we know about anaphylactic reactions to Astrazeneca, Pfizer, Moderna, Johnson & Johnson & other COVID-19 vaccines?
    Read more

    January 20, 2021: Irritable Bowel and COVID-19 : Abdominal pain is less widely known as a symptom of COVID-19, yet it is  - along with shortness of breath and confusion - a potential sign of the most severe form of COVID-19. In children, having gastrointestinal symptoms was more frequently associated with severe and critical phenotype.
    Read more